Northern Light Leads $16M Series A Round In China’s Biopharma Firm Kanova

Login to View

Chinese biopharmaceutical firm Kanova has secured RMB115 million (US$16.55 million) series A round of financing from Chinese venture capital firm Northern Light Venture Capital (NLVC), according to a statement released today by NLVC.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in


RELATED NEWS